Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9728)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2015 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mori S, Fujiyama S. Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations. World J Gastroenterol 2015; 21(36): 10274-10289 [PMID: 26420955 DOI: 10.3748/wjg.v21.i36.10274] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i36/10274.htm |
| Number | Citing Articles |
| 1 |
Purva Chhibar, Ziqiang Zhu, Naga K.S. Cheedella, Rashid Chaudhry, Jen Chin Wang. Hepatitis B Reactivation After Ifosfamide Therapy for Retroperitoneal Sarcoma. American Journal of Case Reports 2016; 17: 371 doi: 10.12659/AJCR.896496
|
| 2 |
Claudia Lasagni, Laura Bigi, Andrea Conti, Giovanni Pellacani. Successful therapy of plaque-type psoriasis with secukinumab in patients with multiple comorbidities treated with previous biologic therapies. Journal of Dermatological Treatment 2018; 29(sup2): 5 doi: 10.1080/09546634.2018.1543843
|
| 3 |
Akshitha Thatiparthi, Amylee Martin, Jeffrey Liu, Alexander Egeberg, Jashin J. Wu. Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review. American Journal of Clinical Dermatology 2021; 22(4): 425 doi: 10.1007/s40257-021-00603-w
|
| 4 |
Yangyang Hu, Shaoxian Hu. Systemic Lupus Erythematosus in a Patient with Liver Cirrhosis: Case Report and Literature Review. Open Medicine Journal 2023; 10(1) doi: 10.2174/18742203-v10-e230719-2022-49
|
| 5 |
Hyun‐seok Kim, Ju Dong Yang, Hashem B. El‐Serag, Fasiha Kanwal. Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey. Journal of Viral Hepatitis 2019; 26(5): 596 doi: 10.1111/jvh.13060
|
| 6 |
Chrong-Reen Wang, Hung-Wen Tsai. Autoimmune liver diseases in systemic rheumatic diseases. World Journal of Gastroenterology 2022; 28(23): 2527-2545 doi: 10.3748/wjg.v28.i23.2527
|
| 7 |
Zhuoya Zhang, Wei Deng, Qizhe Wu, Lingyun Sun. Tuberculosis, hepatitis B and herpes zoster in tofacitinib-treated patients with rheumatoid arthritis. Immunotherapy 2019; 11(4): 321 doi: 10.2217/imt-2018-0113
|
| 8 |
Mohsen Moghoofei, Shayan Mostafaei, Amir Ashraf-Ganjouei, Hoda Kavosi, Mahdi Mahmoudi. HBV reactivation in rheumatic diseases patients under therapy: A meta-analysis. Microbial Pathogenesis 2018; 114: 436 doi: 10.1016/j.micpath.2017.12.014
|
| 9 |
Hannah M. Lee, Bubu A. Banini. Updates on Chronic HBV: Current Challenges and Future Goals. Current Treatment Options in Gastroenterology 2019; 17(2): 271 doi: 10.1007/s11938-019-00236-3
|
| 10 |
Bo-Cheng Huang, Yun-Chi Lu, Jun-Min Liao, Hui-Ju Liu, Shih-Ting Hong, Yuan-Chin Hsieh, Chih-Hung Chuang, Huei-Jen Chen, Tzu-Yi Liao, Kai-Wen Ho, Yeng-Tseng Wang, Tian-Lu Cheng. Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodies. Chemical Science 2021; 12(28): 9759 doi: 10.1039/D1SC01748A
|
| 11 |
John A. Thompson, Bryan J. Schneider, Julie Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew Frigault, Brianna Hoffner, Christopher J. Hoimes, Mario Lacouture, Frederick Locke, Matthew Lunning, Nisha A. Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan Oluwole, Sandip P. Patel, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Momen Wahidi, Yinghong Wang, Alyse Johnson-Chilla, Jillian L. Scavone. Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 2019; 17(3): 255 doi: 10.6004/jnccn.2019.0013
|
| 12 |
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñóz-Espinosa, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J. Sierra-Madero, J.F. Sánchez-Ávila, A. Torre-Delgadillo, R. Torres, E.R. Marín-López, D. Kershenobich, E. Wolpert-Barraza. Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B. Revista de Gastroenterología de México (English Edition) 2021; 86(4): 403 doi: 10.1016/j.rgmxen.2021.04.002
|
| 13 |
Daryl R Cheng, Rebecca Barton, Anthea Greenway, Nigel W Crawford. Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients. Expert Review of Vaccines 2016; 15(12): 1567 doi: 10.1080/14760584.2016.1193438
|
| 14 |
Chi Chiu Mok. Hepatitis B and C infection in patients undergoing biologic and targeted therapies for rheumatic diseases. Best Practice & Research Clinical Rheumatology 2018; 32(6): 767 doi: 10.1016/j.berh.2019.03.008
|
| 15 |
Silvia Dettori, Chiara Russo, Sara Mora, Mauro Giacomini, Lucia Taramasso, Chiara Dentone, Antonio Vena, Matteo Bassetti, Antonio Di Biagio. Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2. Journal of Community Health 2022; 47(5): 800 doi: 10.1007/s10900-022-01111-6
|
| 16 |
Norah A. Terrault, Anna S.F. Lok, Brian J. McMahon, Kyong‐Mi Chang, Jessica P. Hwang, Maureen M. Jonas, Robert S. Brown, Natalie H. Bzowej, John B. Wong. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology 2018; 67(4): 1560 doi: 10.1002/hep.29800
|
| 17 |
E. S. Aronova, G. V. Lukina, Ya. A. Sigidin. Infliximab tolerance in patients with rheumatoid arthritis in real clinical practice. Rheumatology Science and Practice 2020; 58(1): 31 doi: 10.14412/1995-4484-2020-31-36
|
| 18 |
Chen Pan, Mingnan Cao, Cilin Yan, Xiaojuan Ou, Xia Zhang, Wanyi Xu, Ye Xu, Xiangli Cui. Hepatitis B virus reactivation associated with Janus kinase (JAK) inhibitors: a retrospective study of pharmacovigilance databases and review of the literature. Expert Opinion on Drug Safety 2023; 22(6): 469 doi: 10.1080/14740338.2023.2181339
|
| 19 |
Zi-Niu Ding, Guang-Xiao Meng, Jun-Shuai Xue, Lun-Jie Yan, Hui Liu, Yu-Chuan Yan, Zhi-Qiang Chen, Jian-Guo Hong, Dong-Xu Wang, Zhao-Ru Dong, Tao Li. Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis. Journal of Cancer Research and Clinical Oncology 2023; 149(5): 1993 doi: 10.1007/s00432-022-04133-8
|
| 20 |
Elisa Gremese, Antonio Gasbarrini, Gianfranco Ferraccioli. HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?. RMD Open 2020; 6(1): e001171 doi: 10.1136/rmdopen-2020-001171
|
| 21 |
Toshiaki Tanaka, Naoya Masumori. Current approach to diagnosis and management of retroperitoneal fibrosis. International Journal of Urology 2020; 27(5): 387 doi: 10.1111/iju.14218
|
| 22 |
I. Carrión-Barberà, A. Pros, T. C. Salman-Monte, F. Vílchez-Oya, J. M. Sánchez-Schmidt, C. Pérez-García, J. Monfort. Safe and successful treatment of refractory polyarteritis nodosa with tocilizumab in a patient with past hepatitis B virus infection: a case-based review. Clinical Rheumatology 2021; 40(5): 2065 doi: 10.1007/s10067-020-05345-4
|
| 23 |
M. Nedim Ince, David E. Elliott. Effective Use of the Laboratory in the Management of Patients with Inflammatory Bowel Diseases. Gastroenterology Clinics of North America 2019; 48(2): 237 doi: 10.1016/j.gtc.2019.02.006
|
| 24 |
Ahmad AlEnizi, Khaled AlSaeid, Adel Alawadhi, Eiman Hasan, Entesar H. Husain, Ahmad AlFadhli, Aqeel Ghanem, Fatemah Abutiban, Yaser Ali, Adeeba Al-Herz, Khuloud Mohammed, Waleed Alkandari, Ali Aldei, Hebah Alhajeri, Ahmad Dehrab, Sawsan Hayat. Kuwait Recommendations on Vaccine Use in People with Inflammatory Rheumatic Diseases. International Journal of Rheumatology 2018; 2018: 1 doi: 10.1155/2018/5217461
|
| 25 |
Shunsuke Mori, Michihiro Hidaka, Toshiro Kawakita, Toshihiko Hidaka, Hiroyuki Tsuda, Tamami Yoshitama, Kiyoshi Migita, Yukitaka Ueki, Masataka Kuwana. Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases. PLOS ONE 2016; 11(4): e0154744 doi: 10.1371/journal.pone.0154744
|
| 26 |
Inkin Ujiie, Hideyuki Ujiie, Norihiro Yoshimoto, Hiroaki Iwata, Hiroshi Shimizu. Prevalence of infectious diseases in patients with autoimmune blistering diseases. The Journal of Dermatology 2020; 47(4): 378 doi: 10.1111/1346-8138.15244
|
| 27 |
婷 姚. Advances in Clinical Study of Tofacitinib in the Treatment of Rheumatoid Arthritis. Advances in Clinical Medicine 2021; 11(11): 5009 doi: 10.12677/ACM.2021.1111736
|
| 28 |
Marcia A. Friedman, Kevin L. Winthrop. Vaccines and Disease-Modifying Antirheumatic Drugs. Rheumatic Disease Clinics of North America 2017; 43(1): 1 doi: 10.1016/j.rdc.2016.09.003
|
| 29 |
Gabriel Pacífico Seabra Nunes, Patrícia da Silva Cunha, Daniele Patrícia Dal Bosco, Sandra Lúcia Euzébio Ribeiro. Challenging Management of Hepatitis B infection in Ankylosing Spondylitis Patients in an Endemic Area during Immunosuppressive Therapy. Revista da Sociedade Brasileira de Medicina Tropical 2019; 52 doi: 10.1590/0037-8682-0386-2018
|
| 30 |
Jiang Su, Li Long, Kun Zou. Antiviral prophylaxis for preventing reactivation of hepatitis B virus in rheumatic patients: a systematic review and meta-analysis. Clinical Rheumatology 2018; 37(12): 3201 doi: 10.1007/s10067-018-4096-0
|
| 31 |
Sung Soo Ahn, Seung Min Jung, Jason Jungsik Song, Yong-Beom Park, Jun Yong Park, Sang-Won Lee. Safety of Tocilizumab in Rheumatoid Arthritis Patients with Resolved Hepatitis B Virus Infection: Data from Real-World Experience. Yonsei Medical Journal 2018; 59(3): 452 doi: 10.3349/ymj.2018.59.3.452
|
| 32 |
E. S. Aronova, G. V. Lukina. Safety of infliximab in real clinical practice. Medical alphabet 2019; 1(18): 39 doi: 10.33667/2078-5631-2019-1-18(393)-39-43
|
| 33 |
Joshua S. Davis, David Ferreira, Emma Paige, Craig Gedye, Michael Boyle. Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies. Clinical Microbiology Reviews 2020; 33(3) doi: 10.1128/CMR.00035-19
|
| 34 |
Igor Snast, Lihi Atzmony, Marius Braun, Emmilia Hodak, Lev Pavlovsky. Risk for hepatitis B and C virus reactivation in patients with psoriasis on biologic therapies: A retrospective cohort study and systematic review of the literature. Journal of the American Academy of Dermatology 2017; 77(1): 88 doi: 10.1016/j.jaad.2017.01.037
|
| 35 |
W Afzal, M Haghi, SA Hasni, KA Newman. Lupus hepatitis, more than just elevated liver enzymes. Scandinavian Journal of Rheumatology 2020; 49(6): 427 doi: 10.1080/03009742.2020.1744712
|
| 36 |
Marcia A. Friedman, Kevin Winthrop. Vaccinations for rheumatoid arthritis. Current Opinion in Rheumatology 2016; 28(3): 330 doi: 10.1097/BOR.0000000000000281
|
| 37 |
James Cheng‐Chung Wei, Chin‐Hsiu Liu, Jui‐Cheng Tseng, Lin‐Fen Hsieh, Chun‐Hsiung Chen, Hsin‐Hua Chen, Hung‐An Chen, Ying‐Chou Chen, Chung‐Tei Chou, Hsien‐Tzung Liao, Yi‐Chun Lin, Shue‐Fen Luo, Deng‐Ho Yang, Kai‐Jieh Yeo, Wen‐Chan Tsai. Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis. International Journal of Rheumatic Diseases 2020; 23(1): 7 doi: 10.1111/1756-185X.13752
|
| 38 |
Dimitrios C Ziogas, Frosso Kostantinou, Evangelos Cholongitas, Amalia Anastasopoulou, Panagiotis Diamantopoulos, John Haanen, Helen Gogas. Reconsidering the management of patients with cancer with viral hepatitis in the era of immunotherapy. Journal for ImmunoTherapy of Cancer 2020; 8(2): e000943 doi: 10.1136/jitc-2020-000943
|
| 39 |
Christos Koutsianas, Konstantinos Thomas, Dimitrios Vassilopoulos. Prevention of HBV reactivation in patients treated with biologic agents. Expert Review of Clinical Pharmacology 2016; 9(4): 579 doi: 10.1586/17512433.2016.1143773
|
| 40 |
Nathaniel C. Nelson, Rebecca Kogan, Rany Condos, Kerry M. Hena. Emerging Therapeutic Options for Refractory Pulmonary Sarcoidosis: The Evidence and Proposed Mechanisms of Action. Journal of Clinical Medicine 2023; 13(1): 15 doi: 10.3390/jcm13010015
|
| 41 |
Meng Hsuan Kuo, Chih-Wei Tseng, Chi-Hui Lee, Chien-Hsueh Tung, Kuo-Chih Tseng, Ning-Sheng Lai. Moderate Risk of Hepatitis B Virus Reactivation in HBsAg−/HBcAb+ Carriers Receiving Rituximab for Rheumatoid Arthritis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-59406-4
|
| 42 |
Andrew Ustianowski, Karen Devine. Infections in Systemic Autoimmune Diseases: Risk Factors and Management. Handbook of Systemic Autoimmune Diseases 2020; 16: 59 doi: 10.1016/B978-0-444-64217-2.00004-X
|
| 43 |
Marco Canzoni, Massimo Marignani, Maria Laura Sorgi, Paola Begini, Michela Ileen Biondo, Sara Caporuscio, Vincenzo Colonna, Francesca Della Casa, Paola Conigliaro, Cinzia Marrese, Eleonora Celletti, Irene Modesto, Mario Stefano Peragallo, Bruno Laganà, Andrea Picchianti-Diamanti, Roberta Di Rosa, Claudia Ferlito, Simonetta Salemi, Raffaele D’Amelio, Tommaso Stroffolini. Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy. Microorganisms 2020; 8(11): 1792 doi: 10.3390/microorganisms8111792
|
| 44 |
Kenji Oku, Laniyati Hamijoyo, Nuntana Kasitanon, Meng Tao Li, Sandra Navarra, Eric Morand, Yoshiya Tanaka, Chi Chiu Mok. Prevention of infective complications in systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements. International Journal of Rheumatic Diseases 2021; 24(7): 880 doi: 10.1111/1756-185X.14125
|
| 45 |
Stefano Piaserico, Francesco Messina, Francesco Paolo Russo. Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations. American Journal of Clinical Dermatology 2019; 20(6): 829 doi: 10.1007/s40257-019-00457-3
|
| 46 |
Soo-Kyung Park, Chang Hwan Choi, Jaeyoung Chun, Heeyoung Lee, Eun Sun Kim, Jae Jun Park, Chan Hyuk Park, Bo-In Lee, Yunho Jung, Dong-Il Park, Do Young Kim, Hana Park, Yoon Tae Jeen. Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases. Intestinal Research 2020; 18(1): 18 doi: 10.5217/ir.2019.09155
|
| 47 |
Lorenzo Onorato, Mariantonietta Pisaturo, Clarissa Camaioni, Pierantonio Grimaldi, Alessio Vinicio Codella, Federica Calò, Nicola Coppola. Risk and Prevention of Hepatitis B Virus Reactivation during Immunosuppression for Non-Oncological Diseases. Journal of Clinical Medicine 2021; 10(21): 5201 doi: 10.3390/jcm10215201
|
| 48 |
J. Steuart Richards, Sharon Dowell, Mercedes Quinones. Comorbidity in Rheumatic Diseases. 2017; : 345 doi: 10.1007/978-3-319-59963-2_17
|
| 49 |
Masahiro Kamata, Yayoi Tada. Safety of biologics in psoriasis. The Journal of Dermatology 2018; 45(3): 279 doi: 10.1111/1346-8138.14096
|
| 50 |
Rodolfo Perez-Alamino. Infections and the Rheumatic Diseases. 2019; : 107 doi: 10.1007/978-3-030-23311-2_10
|
| 51 |
Yun-Chi Lu, Chih-Hung Chuang, Kuo-Hsiang Chuang, I-Ju Chen, Bo-Cheng Huang, Wen-Han Lee, Hsin-Ell Wang, Jia-Je Li, Yi-An Cheng, Kai-Wen Cheng, Jaw-Yuan Wang, Yuan-Chin Hsieh, Wen-Wei Lin, Tian-Lu Cheng, Ken Cadwell. Specific activation of pro-Infliximab enhances selectivity and safety of rheumatoid arthritis therapy. PLOS Biology 2019; 17(6): e3000286 doi: 10.1371/journal.pbio.3000286
|
| 52 |
Asako Tagawa. Infectious issues of therapeutic monoclonal antibodies in multiple sclerosis and neuromyelitis optica spectrum disorders. Clinical and Experimental Neuroimmunology 2022; 13(3): 143 doi: 10.1111/cen3.12721
|
| 53 |
Mary Patricia Pauly, Lue-Yen Tucker, Jean-Luc Szpakowski, Joanna B. Ready, David Baer, Jessica Hwang, Anna S.-F. Lok. Incidence of Hepatitis B Virus Reactivation and Hepatotoxicity in Patients Receiving Long-term Treatment With Tumor Necrosis Factor Antagonists. Clinical Gastroenterology and Hepatology 2018; 16(12): 1964 doi: 10.1016/j.cgh.2018.04.033
|
| 54 |
Longfei Li, Linlin Wang, Chunyu Huang, Lianghui Diao, Yongnu Zhang, Xu Zhang, Jian Xu, Yong Zeng. Chronic hepatitis B infection alters peripheral immune response in women with reproductive failure. American Journal of Reproductive Immunology 2019; 81(3) doi: 10.1111/aji.13083
|
| 55 |
Perry K Pratt, Nunes David, Horst C Weber, Frédéric F Little, Themistoklis Kourkoumpetis, Gregory J Patts, Janice Weinberg, Francis A Farraye. Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy. Inflammatory Bowel Diseases 2018; 24(2): 380 doi: 10.1093/ibd/izx001
|
| 56 |
E. V. Kalinina, M. A. Zvonorenko, A. A. Ansarova, V. P. Goloskova, A. R. Babaeva. Comorbidity in inflammatory diseases of joints and spine (clinical aspects). Medical alphabet 2023; (9): 17 doi: 10.33667/2078-5631-2023-9-17-24
|
| 57 |
E. E. Gubar, T. V. Korotaeva, A. S. Starkova, M. M. Urumova. The safety and optimal dosage of an interleukin-17A inhibitor (secukinumab) in the treatment of psoriatic arthritis in a patient with concomitant hepatitis C virus infection. Modern Rheumatology Journal 2019; 13(4): 79 doi: 10.14412/1996-7012-2019-4-79-83
|
| 58 |
Risa Fuller, Samantha E. Jacobs. Molecular Medical Microbiology. 2024; : 2605 doi: 10.1016/B978-0-12-818619-0.00110-6
|
| 59 |
Anne Y. Liu. Infectious Implications of Interleukin-1, Interleukin-6, and T Helper Type 2 Inhibition. Infectious Disease Clinics of North America 2020; 34(2): 211 doi: 10.1016/j.idc.2020.02.003
|
| 60 |
Christopher R Holroyd, Rakhi Seth, Marwan Bukhari, Anshuman Malaviya, Claire Holmes, Elizabeth Curtis, Christopher Chan, Mohammed A Yusuf, Anna Litwic, Susan Smolen, Joanne Topliffe, Sarah Bennett, Jennifer Humphreys, Muriel Green, Jo Ledingham. The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis. Rheumatology 2019; 58(2): e3 doi: 10.1093/rheumatology/key208
|
| 61 |
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñóz-Espinosa, J.L. Pérez-Hernández, M.V. Ramos-Gómez, J. Sierra-Madero, J.F. Sánchez-Ávila, A. Torre-Delgadillo, R. Torres, E.R. Marín-López, D. Kershenobich, E. Wolpert-Barraza. Asociación Mexicana de Hepatología A.C. Guía Clínica de Hepatitis B. Revista de Gastroenterología de México 2021; 86(4): 403 doi: 10.1016/j.rgmx.2021.04.002
|
| 62 |
Biljana Radovanović-Dinić, Snežana Tešić-Rajković, Valentina Zivkovic, Saša Grgov. Clinical connection between rheumatoid arthritis and liver damage. Rheumatology International 2018; 38(5): 715 doi: 10.1007/s00296-018-4021-5
|
| 63 |
Caterina Sagnelli, Laura Montella, Pierantonio Grimaldi, Mariantonietta Pisaturo, Loredana Alessio, Stefania De Pascalis, Evangelista Sagnelli, Nicola Coppola. COVID-19 as Another Trigger for HBV Reactivation: Clinical Case and Review of Literature. Pathogens 2022; 11(7): 816 doi: 10.3390/pathogens11070816
|
| 64 |
Sarah Patterson, Gabriela Schmajuk, Michael Evans, Ishita Aggarwal, Zara Izadi, Milena Gianfrancesco, Jinoos Yazdany. Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications. The Joint Commission Journal on Quality and Patient Safety 2019; 45(5): 348 doi: 10.1016/j.jcjq.2018.12.003
|
| 65 |
Christos Koutsianas, Konstantinos Thomas, Dimitrios Vassilopoulos. Hepatitis B Reactivation in Rheumatic Diseases. Rheumatic Disease Clinics of North America 2017; 43(1): 133 doi: 10.1016/j.rdc.2016.09.012
|
| 66 |
Masayoshi Harigai, Kevin Winthrop, Tsutomu Takeuchi, Tsu-Yi Hsieh, Yi-Ming Chen, Josef S Smolen, Gerd Burmester, Chad Walls, Wen-Shuo Wu, Christina Dickson, Ran Liao, Mark C Genovese. Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis. RMD Open 2020; 6(1): e001095 doi: 10.1136/rmdopen-2019-001095
|
| 67 |
Sami Fidan, Erhan Capkın, Deniz Aksu Arıca, Serdar Durak, Ilyas Ercan Okatan. Risk of hepatitis B reactivation in patients receiving anti‐tumor necrosis factor‐α therapy. International Journal of Rheumatic Diseases 2021; 24(2): 254 doi: 10.1111/1756-185X.14034
|
| 68 |
Yaser Ali, Fatemah Abutiban, Adel Alawadhi, Ali AlDei, Ahmad Alenizi, Hebah Alhajeri, Adeeba Al-Herz, Waleed Alkandari, Ahmad Dehrab, Eman Hasan, Sawsan Hayat, Aqeel Ghanem, Khulood Saleh, Xenofon Baraliakos. <p>Recommendation for the Management of Spondyloarthritis Patients in Kuwait</p>. Open Access Rheumatology: Research and Reviews 2020; : 147 doi: 10.2147/OARRR.S246246
|
| 69 |
Ioannis Braimakis, Sofia Vasileiadi, Eleni-Myrto Trifylli, Nikolaos Papadopoulos, Melanie Deutsch. Can Hepatitis B Virus (HBV) Reactivation Result from a Mild COVID-19 Infection?. Livers 2023; 3(3): 347 doi: 10.3390/livers3030026
|
| 70 |
Eiichi Ogawa, Mike T. Wei, Mindie H. Nguyen. Hepatitis B Virus Reactivation Potentiated by Biologics. Infectious Disease Clinics of North America 2020; 34(2): 341 doi: 10.1016/j.idc.2020.02.009
|
| 71 |
Sz‐Tsan Wang, Chih‐Wei Tseng, Chia‐Wen Hsu, Chien‐Hsueh Tung, Kuang‐Yung Huang, Ming‐Chi Lu, Ning‐Sheng Lai. Reactivation of hepatitis B virus infection in patients with rheumatoid arthritis receiving tofacitinib. International Journal of Rheumatic Diseases 2021; 24(11): 1362 doi: 10.1111/1756-185X.14217
|
| 72 |
Zhu Jiayu, Qingyuan Zhang. Hepatitis B virus–associated diffuse large B cell lymphoma: epidemiology, biology, clinical features and HBV reactivation. Holistic Integrative Oncology 2023; 2(1) doi: 10.1007/s44178-023-00061-w
|
| 73 |
Toshihisa Matsuzaki, Katsumi Eguchi, Natsumi Nagao, Sousuke Tsuji, Toshiyuki Aramaki, Kaoru Terada, Shinichi Iwatsu, Ikuko Tokimura, Yasuhiro Kamo, Hidetoshi Oda, Noboru Kinoshita, Hisamitsu Miyaaki, Naota Taura, Tatsuki Ichikawa, Atsushi Kawakami, Kazuhiko Nakao, Yukitaka Ueki. Hepatitis B virus reactivation in patients with rheumatoid arthritis: A single-center study. Modern Rheumatology 2018; 28(5): 808 doi: 10.1080/14397595.2017.1419842
|